What are the differential diagnoses for a choroidal infection that mimics cryptococcosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Differential Diagnosis for Cryptococcus-Like Choroidal Infection

When evaluating choroidal lesions that resemble cryptococcal infection, the primary differential diagnoses include tuberculous choroiditis (serpiginous-like pattern), other fungal infections (particularly Aspergillus), and non-infectious mimics such as central serous chorioretinopathy or intraocular lymphoma.

Key Diagnostic Considerations

Primary Infectious Differentials

Tuberculous Choroiditis is the most critical infectious differential to exclude. Mycobacterium tuberculosis can present with serpiginous-like choroidal lesions that closely mimic cryptococcal involvement 1. These lesions typically appear in the peripapillary and posterior pole regions and may initially be misdiagnosed as central serous chorioretinopathy due to associated subretinal fluid. A positive tuberculin skin test or interferon-gamma release assay (IGRA) supports this diagnosis, and specific antitubercular therapy leads to progressive improvement.

Aspergillus Choroiditis should be considered, particularly in immunocompromised patients with documented invasive aspergillosis elsewhere 2. Aspergillus CNS involvement, including ocular dissemination, carries a mortality rate approaching 90% and requires aggressive systemic antifungal therapy with voriconazole as first-line treatment.

Clinical Presentation Patterns

Cryptococcal choroiditis typically manifests as multiple yellowish, placoid-appearing choroidal lesions in the posterior pole 3. This placoid pattern is an unusual variant of multifocal choroiditis and occurs most commonly in AIDS patients with disseminated cryptococcal disease. Importantly, choroidal lesions may precede the presentation of cryptococcal meningitis, making them a critical early warning sign of life-threatening systemic infection 3.

Diagnostic Algorithm

Step 1: Assess Immune Status

  • HIV status and CD4 count
  • History of immunosuppressive medications (corticosteroids, monoclonal antibodies like alemtuzumab or infliximab, tacrolimus, mycophenolate)
  • Solid organ transplant status
  • Underlying malignancy

Step 2: Rule Out CNS Involvement

Perform lumbar puncture in all cases of suspected cryptococcal choroiditis, as cryptococcal meningitis is documented in 17.7% of pulmonary cryptococcosis cases and frequently accompanies ocular involvement 4, 5. CSF should be sent for:

  • Cryptococcal antigen testing
  • India ink stain
  • Fungal culture
  • Opening pressure measurement

Step 3: Systemic Evaluation

  • Serum cryptococcal antigen (sensitivity for disseminated disease)
  • Chest CT to evaluate for pulmonary involvement (nodules/masses are the most common pattern in 73.9-79.5% of cases) 5
  • Blood cultures for fungemia
  • Skin examination for papular, umbilicated, ulcerated lesions suggestive of disseminated cryptococcosis 3

Step 4: Tuberculosis Screening

  • Tuberculin skin test or IGRA
  • Chest imaging for pulmonary TB
  • Consider this diagnosis especially if serpiginous-like lesions are present 1

Step 5: Consider Other Differentials Based on Pattern

  • If placoid yellowish lesions: Cryptococcus most likely
  • If serpiginous-like pattern: Tuberculosis primary consideration
  • If subretinal fluid without vitritis: Consider central serous chorioretinopathy initially, but maintain high suspicion for infectious causes if unresponsive to standard therapy 1

Critical Pitfalls to Avoid

Do not assume immunocompetence excludes cryptococcosis. Pulmonary cryptococcosis is increasingly identified in patients with no recorded immunocompromising conditions (62.9% in one cohort), and asymptomatic/incidental presentation occurs in 30.8% of these cases 5.

Do not rely solely on CSF smear and culture. Cryptococcomas forming gelatinous pseudocysts can lead to false-negative smear and culture reports, causing diagnostic delays 6. Cryptococcal antigen testing in both serum and CSF is essential, though even these may be weakly positive in some cases.

Do not overlook the need for ophthalmology consultation. Management of ocular cryptococcal infections requires individualized therapeutic strategy depending on extent of eye structure involvement, ranging from systemic combinations of amphotericin B with high eye-penetration drugs (flucytosine and/or fluconazole) to adjunctive intravitreal amphotericin B 4.

Treatment Implications

If cryptococcal choroiditis is confirmed or highly suspected with evidence of dissemination (cryptococcemia, involvement of ≥2 noncontiguous sites, or cryptococcal antigen titer ≥1:512), treat as CNS disease with amphotericin B deoxycholate (0.7-1.0 mg/kg/day IV) plus flucytosine (100 mg/kg/day orally in 4 divided doses) for at least 2 weeks, followed by fluconazole consolidation 4.

For tuberculous choroiditis, initiate specific antitubercular therapy immediately upon diagnosis, as this leads to progressive improvement 1.

References

Related Questions

How should a patient with a one-month history of fever and cough be evaluated and managed for suspected cryptococcosis?
What are the clinical manifestations and recommended treatment for Cryptococcus species infection?
Should cryptococcus detected in cerebrospinal fluid be treated?
How should the opioid regimen be adjusted for a patient on morphine patient‑controlled analgesia (PCA) with a 1 mg demand dose, 5‑minute lockout, and a 1 mg/h basal infusion who has taken more than four breakthrough doses in the past 24 hours?
For a patient on a morphine patient‑controlled analgesia (PCA) pump who has required more than four rescue doses in the last 24 hours, what breakthrough dose should be given?
Is the description of Dravet syndrome and the approval, pricing, and availability of DIACOMIT (stiripentol) for patients aged six months and older in Brazil accurate?
When should Trintellix (vortioxetine) be taken, and does it cause sedation or insomnia?
Is 0.25 mg of digoxin equivalent to 250 µg (micrograms) of digoxin?
Is a serum immunoglobulin A level of 79 mg/dL considered low, and what evaluation and management steps are recommended?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.